Charged trastuzumab ADC plasma disposition
A reduced plasma PK model representing first-order elimination, concentration, half-life, and cumulative exposure of a positively charged trastuzumab-vc-MMAE ADC.
- Therapeutic
- Positively charged trastuzumab-vc-MMAE ADC, trastuzumab
- Target
- HER2 / ERBB2
- Disease
- HER2-positive preclinical tumor models
Biological model
A reduced plasma PK model representing first-order elimination, concentration, half-life, and cumulative exposure of a positively charged trastuzumab-vc-MMAE ADC.
Intervention
Positively charged trastuzumab-vc-MMAE ADC, trastuzumab
Biological focus
HER2 / ERBB2
Context
HER2-positive preclinical tumor models
Model details
A reduced plasma PK model representing first-order elimination, concentration, half-life, and cumulative exposure of a positively charged trastuzumab-vc-MMAE ADC.
Modeled states
- AUC h nMh*nM
Modeled dynamic state for auc h nm.
- C nMnM
Modeled dynamic state for c nm.
- elapsed hh
Modeled dynamic state for elapsed h.
Key readouts
- Plasma ADC concentrationnM
Model-derived readout for plasma adc concentration.
- Cumulative plasma ADC exposureh*nM
Model-derived readout for cumulative plasma adc exposure.
- ADC half-lifeunknown
Model-derived readout for adc half-life.
- elapsed hh
Model-derived readout for elapsed h.
- ode auc endpoint h nMunknown
Model-derived readout for ode auc endpoint h nm.
Explore this model
Choose a starting point to view its result. Adjust key model inputs when you want to explore a different outcome.
Charged trastuzumab ADC plasma disposition
Explore how the starting plasma concentration and first-order elimination rate determine charged trastuzumab ADC concentration, half-life, and cumulative plasma exposure. This is a mechanistic product exploration, not a paper-result reproduction.
Questions to explore
- How does the elimination rate determine plasma ADC concentration, half-life, and exposure?
Starting result
This result reflects the starting settings. Run your changes to update it.
Model inputs
Five scientist-facing controls at most.
Compare a parameter
How does one model input change the response?
How does the elimination rate determine plasma ADC concentration, half-life, and exposure?
kel 1 h
Model parameter controlling kel 1 h.
Exploratory range around the default value.
5 evenly spaced values in 1/h. Other model inputs and the simulation window stay fixed.
Interpret with care
- Interpret trajectories as deterministic model behavior, not as a patient-specific prediction or dosing recommendation.
- Paper-result and exact-anchor checks remain in the private validation lane and are not part of this public scenario.
Review the server-confirmed fixed price before starting the comparison.
Comparative response
End-of-window response across the selected parameter values.
Choose an exploratory range around the default, review the fixed price, and run the comparison.
